A drug used to avoid mother-to-child transmission of HIV-1.
A drug used to avoid mother-to-child transmitting of HIV-1 induces level of resistance more often than previously thought The incidence of drug resistance connected with single-dose nevirapine, a drug used to avoid mother-to-child transmission of HIV-1, may be substantially greater than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online www.medicine-rx.com . A single dose of nevirapine given to an HIV-infected pregnant female during delivery, and another directed at her newborn, can slice the rate of mother-to-child HIV transmitting in two.
Already people have portable technology for gene sequencing. There are wireless technology that would be able to send the barcode data to a central database for matching and receive the result. What’s still required is definitely miniaturisation of the complete platform – the entire sample preparation. But several groups are working on this.’ A hand-held system would allow people to perform quick identification of specimens in the field – in a rainfall forest, for instance, or, closer to home, in a hospital where microbiologists need to identify pathogenic organisms. For example, an increasing numbers of immuno-suppressed sufferers are developing attacks with organisms which were not previously referred to as pathogens. Fast and dependable identification of novel illnesses can save those patients lives.